{
  "id": 16194488,
  "title": "Bolt Biotherapeutics Announces Acquisition Of Prana Therapies, $120 Mln Concurrent Private Placement",
  "url": "https://urgent.news/2026/10/23/bolt-biotherapeutics-announces-acquisition-of-prana-therapies-120-mln",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-23T13:58:59.000Z",
  "source": {
    "name": "Nasdaq Markets",
    "slug": "nasdaq-markets",
    "url": "https://www.nasdaq.com/articles/bolt-biotherapeutics-announces-acquisition-prana-therapies-120-mln-concurrent-private"
  },
  "original_language": "en",
  "account": null,
  "summary": "(RTTNews) - Friday, Bolt Biotherapeutics, Inc. (BOLT) announced its acquisition of Prana Therapies, Inc. through a stock-for-stock transaction aimed at advancing Prana's pipeline of half-life-extended multispecific antibodies developed using its proprietary INSPIRE platform.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}